A double-blind study is an experiment in which neither participants nor researchers know who is receiving the real treatment or a placebo. This double layer of blinding controls for both participant-side demand characteristics and experimenter expectancy, the two main sources of bias in a trial.
What Is a Double-Blind Procedure?
- Binding, or masking, refers to withholding information regarding treatment allocation from one or more participants in a clinical research study, typically in randomized control trials.
- A blinded study prevents the participants from knowing about their treatment to avoid bias in the research. Any information that can influence the subjects is withheld until the completion of the research.
- Blinding can be imposed on any participant in an experiment, including researchers, data collectors, evaluators, technicians, and data analysts.
- Good blinding can eliminate experimental biases arising from the subjects’ expectations, observer bias, confirmation bias, researcher bias, observer’s effect on the participants, and other biases that may occur in a research test.
- Studies may use single-, double- or triple-blinding. A trial that is not blinded is called an open trial.
Double-Blind Studies
Double-blind studies are those in which neither the participants nor the experimenters know who is receiving a particular treatment.
Double blinding prevents bias in research results, specifically due to demand characteristics or the placebo effect.
Demand characteristics are subtle cues from researchers that can inform the participants of what the experimenter expects to find or how participants are expected to behave.
Where did this idea come from?
Aim: Martin Orne (1962) aimed to show that participants are not passive responders to an experiment, but active, motivated interpreters of the whole situation.
Method: Orne drew on his own laboratory studies, including tasks where participants repeatedly added random numbers and then tore up the sheets. He combined this with a wider review of the period’s social psychology research.
The results were striking.
Findings: Participants routinely tried to guess the experimenter’s hypothesis and then adjusted their behaviour to confirm it, becoming “good subjects” rather than honest responders to the treatment itself.
Conclusion: Any experiment that lets a participant infer its hypothesis risks measuring compliance with that guess, not the real effect of the treatment. Orne called these cues demand characteristics.
If participants know which group they are assigned to, they might change their behavior in a way that would influence the results. The same risk applies to researchers.
If they know a participant’s group, they might act in a way that reveals the assignment or influences the results. Double-blinding attempts to prevent these risks, ensuring that any difference(s) between the groups can be attributed to the treatment. On the other hand, single-blind studies work differently.
Only the experimenters know who is receiving the treatment; the participants do not. Single-blind studies are beneficial because they reduce the risk of errors due to subject expectations. However, single-blind studies do not prevent observer bias, confirmation bias, or bias due to demand characteristics. That gap matters in practice.
Because the experimenters are aware of which participants are receiving which treatments, they are more likely to reveal subtle clues that can accidentally influence the research outcome.
Double-blind studies are considered the gold standard in research. They control for both the subjects’ expectations and experimenter biases, the two channels through which researchers can unknowingly influence how subjects respond or how data is recorded.
One classic study shows exactly this.
Aim: Rosenthal and Fode (1963) aimed to test whether an experimenter’s own expectations could influence a study’s results, even without any deliberate intention to bias the data.
The setup was simple.
Method: Student experimenters were given genetically identical rats and asked to time how quickly each learned a maze. Half were told their rats were bred to be fast learners. The other half were told their rats were bred to be slow learners.
The results were clear.
Findings: Rats whose handlers believed them fast learners learned the maze significantly faster than rats whose handlers believed them slow learners. The rats did not actually differ in ability at all.
Conclusion: An experimenter’s expectations can unintentionally shape a study’s outcome, even with no conscious intention to bias the result. This is the exact channel that double-blinding is designed to close.
Using the double-blind method improves the credibility and validity of a study.
Example Double-Blind Studies
Rostock and Huber (2004) used a randomized, placebo-controlled, double-blind study to investigate the immunological effects of mistletoe extract. However, their study found a limit to blinding. Double-blinding is impossible when the investigated therapy has obvious side effects.
Using a double-blind study, Kobak et al. (2005) found that St John’s wort (Hypericum perforatum) is not an efficacious treatment for obsessive-compulsive disorder (OCD).
Using the Yale–Brown Obsessive–Compulsive Scale (Y-BOCS), they found that the mean change with St John’s wort was not significantly different from the mean change found with placebo.
Cakir et al. (2014) conducted a randomized, controlled, and double-blind study to test the efficacy of therapeutic ultrasound for managing knee osteoarthritis.
All assessment parameters improved significantly in every group. There was no significant difference between them, suggesting therapeutic ultrasound added no extra benefit to exercise training alone.
Using a randomized double-blind study, Papachristofilou et al. (2021) tested whole-lung low-dose radiation therapy in critically ill COVID-19 patients on mechanical ventilation. It failed to improve their clinical outcomes.
Double-Blinding Procedure
Double blinding is typically used in clinical research studies or clinical trials to test the safety and efficacy of various biomedical and behavioral interventions.
In such studies, researchers tend to use a placebo. A placebo is an inactive substance, usually a sugar pill, made to look like the real drug or treatment but with no active effect.
The two groups should look identical.
The placebo pill was given to the participants who were randomly assigned to the control group. This group serves as a baseline to determine if exposure to the treatment had any significant effects.
Those randomly assigned to the experimental group are given the actual treatment in question. Data is collected from both groups.
The two sets of results are then compared to see whether the treatment had any impact on the dependent variable.
All participants in the study take a pill or receive a treatment. Only some of them receive the real treatment under investigation; the rest receive a placebo.
Nobody knows which is which.
With double blinding, neither the participants nor the experimenters know who receives the real drug and who receives the placebo.
For Example
A common example of double-blinding is clinical studies that are conducted to test new drugs.
In these studies, researchers use random assignment to allocate patients into one of three groups.
- Treatment group: receives the actual drug being tested.
- Placebo group: receives an inactive substance that looks identical to the treatment but contains no drug.
- Control group: receives no treatment at all, serving as the baseline.
Both participants and researchers are kept unaware of which participants are allocated to which of the three groups.
The effects of the drug are measured by recording symptoms. Researchers note anything patients report.
Once the study is unblinded, researchers and participants learn who was in which group. The data can then be analyzed to see whether the drug had effects that went beyond the placebo or control group.
Double-blind studies can also be beneficial in nonmedical interventions, such as psychotherapies.
Advantages
Reduces risk of bias
Double-blinding can eliminate, or significantly reduce, both observer bias and participant biases.
Because both the researcher and the subjects are unaware of the treatment assignments, it is difficult for their expectations or behaviors to influence the study.
Results can be duplicated
The results of a double-blind study can be duplicated, enabling other researchers to follow the same processes, apply the same test item, and compare their results with the control group.
If the results are similar, then it adds more validity to the ability of a medication or treatment to provide benefits. This matters more than it might seem.
A large project that tried to directly replicate 100 published psychology studies found that only 36% reproduced the original result (Open Science Collaboration, 2015). A precisely documented, standardised procedure, of which blinding is one part, is what makes that kind of check possible in the first place.
It tests for three groups
Double-blind studies usually involve three groups of subjects: the treatment group, the placebo group, and the control group.
The treatment and placebo groups are both given the test item, although the researcher does not know which group is getting real treatment or placebo treatment.
The control group doesn’t receive anything because it serves as the baseline against which the other two groups are compared.
This design lets researchers separate two different effects. A placebo group that improves more than the control group reveals a placebo effect. A treatment group that improves more than the placebo group reveals the treatment’s own effect.
Applicable across multiple industries
Double-blind studies can be used across multiple industries, such as agriculture, biology, chemistry, engineering, and social sciences.
Double-blind studies are used primarily by the pharmaceutical industry because researchers can look directly at the impact of medications.
The same logic now runs at huge scale online. Large technology companies routinely randomly assign visitors to see one version of a webpage or price against another, an approach known as A/B testing. They then compare outcomes such as click-through or purchase rates.
Kohavi et al. (2013) describe organisations running thousands of these randomised online experiments a year. They use the same core logic covered here: random allocation to remove selection bias, and a genuine control arm to provide the baseline.
Disadvantages
Inability to blind
In some types of research, specifically therapeutic, the treatment cannot always be disguised from the participant or the experimenter. In these cases, you must rely on other methods to reduce bias.
Additionally, imposing blinding may be impossible or unethical for some studies.
Costly
Double-blinding can be expensive because the researcher has to examine all the possible variables and may have to use different groups to gather enough data.
Small Sample Size
Most double-blind studies are too small to provide a representative sample. To be effective, it is generally recommended that double-blind trials include around 100-300 participants.
Studies involving fewer than 30 participants generally can’t provide proof of a theory.
Negative Reaction to Placebo
In some instances, participants can have adverse reactions to the placebo, even producing unwanted side effects as if they were taking a real medication.
It doesn’t reflect real-life circumstances
When participants receive treatment or medication in a double-blind placebo study, each individual is told that the item in question might be real medication or a placebo.
This artificial situation does not reflect real life. When a patient receives a pill from a doctor outside a study, they are told it is real medicine meant to help them.
When situations don’t feel realistic to a participant, then the quality of the data can decrease exponentially.
Critical Evaluation
For decades, the case for double-blinding rested mainly on logic: without it, a rival explanation cannot be ruled out. A newer strand of research asks a more direct question. Across real trials, does blinding actually change the results researchers report?
Tight control has a real cost, too.
The same lab conditions that make blinding possible can make the situation feel unlike ordinary life. Participants often notice this artificiality and adjust their behaviour to what they think the situation demands, exactly the demand-characteristics effect described above.
Placebo and blinding controls raise real ethical questions too. Randomly giving a patient an inert placebo can mean withholding a treatment they hope will help them.
The St John’s wort trial above shows the same tension, since some patients unknowingly received no active treatment at all.
Contemporary Research
Page and colleagues (2016) reviewed known trial design flaws.
They wanted to know how far these flaws inflate the size of a trial’s reported effect, and whether this differs by outcome type.
The authors combined the results of 24 existing studies using meta-analysis, each of which had already compared trials with and without a specific design feature.
Blinding was the biggest factor. Trials that failed to double-blind exaggerated subjective outcomes, such as pain or symptom ratings, by around 23% on average. Objective outcomes, like mortality, barely moved.
This bias is concentrated exactly where subjective judgement enters the outcome measure, and it produces a consistent, predictable inflation of reported treatment effects. In short, blinding is not a formality. Removing it changes the answer a trial reports, in a direction that favours the treatment being tested.
This finding fits a wider pattern in psychology.
A large project directly replicated 100 published studies and found only 36% reproduced the original effect.
In response, researchers proposed a package of reforms: pre-registration, larger samples, and blinding of data analysis wherever possible (Open Science Collaboration, 2015; Munafò et al., 2017).
Together, these findings support the article’s core claim. Double-blinding is not just traditional practice; it is one of the few design choices shown, at scale, to change the answer a trial produces.
FAQs
What is the difference between a single-blind, double-blind, and triple-blind study?
In a single-blind study, the experimenters are aware of which participants are receiving the treatment while the participants are unaware.
In a double-blind study, neither the patients nor the researchers know which study group the patients are in. In a triple-blind study, neither the patients, clinicians, nor the people carrying out the statistical analysis know which treatment the subjects had.
Is a double-blind study the same as a randomized clinical trial?
Yes, a double-blind study is a form of a randomized clinical trial in which neither the participants nor the researcher know if a subject is receiving the experimental treatment, a standard treatment, or a placebo.
Are double-blind studies ethical?
Double blinding is ethical only if it serves a scientific purpose. In most circumstances, it is unethical to conduct a double-blind placebo controlled trial where standard therapy exists.
What is the purpose of randomization using double blinding?
Randomization with blinding avoids reporting bias, since no one knows who is being treated and who is not, and thus all treatment groups should be treated the same. This reduces the influence of confounding variables and improves the reliability of clinical trial results.
Why are double-blind experiments considered the gold standard?
Randomized double-blind placebo control studies are considered the “gold standard” of epidemiologic studies as they provide the strongest possible evidence of causality.
Additionally, because neither the participants nor the researchers know who has received what treatment, double-blind studies minimize the placebo effect and significantly reduce bias.
Can blinding be used in qualitative studies?
Yes, blinding is used in qualitative studies.
Key Takeaways
- Double-Blinding: Neither participants nor researchers know who is receiving the real treatment, controlling for bias from both sides at once.
- Single vs Double-Blind: A single-blind study hides the treatment from participants only; a double-blind study hides it from researchers too.
- Demand Characteristics: Participants often guess a study’s hypothesis and unconsciously act to confirm it, one of the two biases blinding controls for.
- Experimenter Effects: Researchers can unintentionally influence results through subtle cues, even with no intention to bias the data.
- Modern Evidence: A large review of 24 studies found that trials failing to double-blind exaggerated subjectively judged outcomes by around 23% on average.
- Limitations: Blinding is not always possible, for example when a treatment has obvious side effects or cannot be disguised.
References
Cakir, S., Hepguler, S., Ozturk, C., Korkmaz, M., Isleten, B., & Atamaz, F. C. (2014). Efficacy of therapeutic ultrasound for the management of knee osteoarthritis: a randomized, controlled, and double-blind study. American journal of physical medicine & rehabilitation, 93(5), 405-412.
Kobak, K. A., Taylor, L. V., Bystritsky, A., Kohlenberg, C. J., Greist, J. H., Tucker, P., … & Vapnik, T. (2005). St John’s wort versus placebo in obsessive–compulsive disorder: results from a double-blind study. International Clinical Psychopharmacology, 20(6), 299-304.
Kohavi, R., Deng, A., Frasca, B., Walker, T., Xu, Y., & Pohlmann, N. (2013). Online controlled experiments at large scale. Proceedings of the 19th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, 1168–1176.
Munafò, M. R., Nosek, B. A., Bishop, D. V. M., Button, K. S., Chambers, C. D., Percie du Sert, N., Simonsohn, U., Wagenmakers, E.-J., Ware, J. J., & Ioannidis, J. P. A. (2017). A manifesto for reproducible science. Nature Human Behaviour, 1, Article 0021.
Open Science Collaboration. (2015). Estimating the reproducibility of psychological science. Science, 349(6251), aac4716.
Orne, M. T. (1962). On the social psychology of the psychological experiment: With particular reference to demand characteristics and their implications. American Psychologist, 17(11), 776–783.
Page, M. J., Higgins, J. P. T., Clayton, G., Sterne, J. A. C., Hróbjartsson, A., & Savović, J. (2016). Empirical evidence of study design biases in randomized trials: Systematic review of meta-epidemiological studies. PLOS ONE, 11(7), e0159267.
Papachristofilou, A., Finazzi, T., Blum, A., Zehnder, T., Zellweger, N., Lustenberger, J., … & Siegemund, M. (2021). Low-dose radiation therapy for severe COVID-19 pneumonia: a randomized double-blind study. International Journal of Radiation Oncology* Biology* Physics, 110(5), 1274-1282.
Rosenthal, R., & Fode, K. L. (1963). The effect of experimenter bias on the performance of the albino rat. Behavioral Science, 8(3), 183–189.
Rostock, M., & Huber, R. (2004). Randomized and double-blind studies–demands and reality as demonstrated by two examples of mistletoe research. Complementary Medicine Research, 11(Suppl. 1), 18-22.
